Australia has granted Papua New Guinea a $570 million loan with conditions for stricter foreign investment screening to curb ...
GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024
as part of PNG. This award supports a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 compared to an approved COVID-19 vaccine. The study is set to commence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback